Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
GIACCONE, Giuseppe, HERBST, Roy S, GATZEMEIER, Ulrich, GROUS, John, OCHS, Judith S, AVERBUCH, Steven D, WOLF, Michael K, RENNIE, Pamela, FANDI, Abderrahim, JOHNSON, David H, MANEGOLD, Christian, SCAGLIOTTI, Giorgio, ROSELL, Rafael, MILLER, Vincent, NATALE, Ronald B, SCHILLER, Joan H, VON PAWEL, Joachim, PLUZANSKA, Anna
Published in Journal of clinical oncology (01.03.2004)
Published in Journal of clinical oncology (01.03.2004)
Get full text
Journal Article
Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2
HERBST, Roy S, GIACCONE, Giuseppe, WOLF, Michael K, KREBS, Annetta D, AVERBUCH, Steven D, OCHS, Judith S, GROUS, John, FANDI, Abderrahim, JOHNSON, David H, SCHILLER, Joan H, NATALE, Ronald B, MILLER, Vincent, MANEGOLD, Christian, SCAGLIOTTI, Giorgio, ROSELL, Rafael, OLIFF, Ira, REEVES, James A
Published in Journal of clinical oncology (01.03.2004)
Published in Journal of clinical oncology (01.03.2004)
Get full text
Journal Article
Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement
Tsimberidou, Apostolia M, Levit, Laura A, Schilsky, Richard L, Averbuch, Steven D, Chen, Daniel, Kirkwood, John M, McShane, Lisa M, Sharon, Elad, Mileham, Kathryn F, Postow, Michael A
Published in Journal of clinical oncology (01.01.2019)
Published in Journal of clinical oncology (01.01.2019)
Get full text
Journal Article
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer: A Randomized Trial
Kris, Mark G, Natale, Ronald B, Herbst, Roy S, Lynch, Jr, Thomas J, Prager, Diane, Belani, Chandra P, Schiller, Joan H, Kelly, Karen, Spiridonidis, Harris, Sandler, Alan, Albain, Kathy S, Cella, David, Wolf, Michael K, Averbuch, Steven D, Ochs, Judith J, Kay, Andrea C
Published in JAMA : the journal of the American Medical Association (22.10.2003)
Published in JAMA : the journal of the American Medical Association (22.10.2003)
Get full text
Journal Article
Quantifying factors for the success of stratified medicine
Trusheim, Mark R, Burgess, Breon, Hu, Sean Xinghua, Long, Theresa, Averbuch, Steven D, Flynn, Aiden A, Lieftucht, Alfons, Mazumder, Abhijit, Milloy, Judy, Shaw, Peter M, Swank, David, Wang, Jian, Berndt, Ernst R, Goodsaid, Federico, Palmer, Michael C
Published in Nature reviews. Drug discovery (01.11.2011)
Published in Nature reviews. Drug discovery (01.11.2011)
Get full text
Journal Article
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
FUKUOKA, Masahiro, YANO, Seiji, EEK, Richard, HORAI, Takeshi, NODA, Kazumasa, TAKATA, Ichiro, SMIT, Egbert, AVERBUCH, Steven, MACLEOD, Angela, FEYEREISLOVA, Andrea, DONG, Rui-Ping, BASELGA, José, GIACCONE, Giuseppe, TAMURA, Tomohide, NAKAGAWA, Kazuhiko, DOUILLARD, Jean-Yves, NISHIWAKI, Yutaka, VANSTEENKISTE, Johan, KUDOH, Shinzoh, RISCHIN, Danny
Published in Journal of clinical oncology (15.06.2003)
Published in Journal of clinical oncology (15.06.2003)
Get full text
Journal Article
Why Oncologists Should Care About Climate Change
Schiller, Joan H, Averbuch, Steven D, Berg, Christine D
Published in JCO oncology practice (01.12.2020)
Published in JCO oncology practice (01.12.2020)
Get more information
Journal Article
Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non–Small-Cell Lung Cancer and Other Solid Tumors: Results of a Phase I Trial
HERBST, Roy S, MADDOX, Anne-Marie, OCHS, Judith, MUCCI LORUSSO, Patricia, ROTHENBERG, Mace L, SMALL, Eric J, RUBIN, Eric H, BASELGA, Jose, ROJO, Federico, WAUN KI HONG, SWAISLAND, Helen, AVERBUCH, Steven D
Published in Journal of clinical oncology (15.09.2002)
Published in Journal of clinical oncology (15.09.2002)
Get full text
Journal Article
Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement
Tsimberidou, Apostolia M, Levit, Laura A, Schilsky, Richard L, Averbuch, Steven D, Chen, Daniel, Kirkwood, John M, McShane, Lisa M, Sharon, Elad, Mileham, Kathryn F, Postow, Michael A
Published in Journal for immunotherapy of cancer (19.10.2018)
Published in Journal for immunotherapy of cancer (19.10.2018)
Get full text
Journal Article
Translating clinical trials into meaningful outcomes
LoRusso, Patricia M, Schnipper, Lowell E, Stewart, David J, Boerner, Scott A, Averbuch, Steven D, Wolf, Walter
Published in Clinical cancer research (15.12.2010)
Published in Clinical cancer research (15.12.2010)
Get full text
Journal Article
Improvements in Quality of Life and Disease-related Symptoms in Phase I Trials of the Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 in Non-Small Cell Lung Cancer and Other Solid Tumors
LORUSSO, Patricia M, HERBST, Roy S, BJORK, Thomas, MADDOX, Anne-Marie, ROTHENBERG, Mace L, SMALL, Eric J, RUBIN, Eric H, FEYEREISLOVA, Andrea, HEYES, Anne, AVERBUCH, Steven D, OCHS, Judith, BASELGA, José, RISCHIN, Danny, RANSON, Malcolm, CALVERT, Hilary, RAYMOND, Eric, KIEBACK, Dirk, KAYE, Stan, GIANNI, Luca, HARRIS, Adrian
Published in Clinical cancer research (01.06.2003)
Get full text
Published in Clinical cancer research (01.06.2003)
Journal Article
Development of the Novel Biologically Targeted Anticancer Agent Gefitinib
Wolf, Michael, Swaisland, Helen, Averbuch, Steven
Published in Clinical cancer research (15.07.2004)
Published in Clinical cancer research (15.07.2004)
Get full text
Journal Article
Treatment of Malignant Pheochromocytoma/ Paraganglioma With Cyclophosphamide, Vincristine, and Dacarbazine : Recommendation From a 22-Year Follow-up of 18 Patients
HUI HUANG, ABRAHAM, Jame, HUNG, Elizabeth, AVERBUCH, Steven, MERINO, Maria, STEINBERG, Seth M, PACAK, Karel, FOJO, Tito
Published in Cancer (15.10.2008)
Published in Cancer (15.10.2008)
Get full text
Journal Article
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer
Fukuoka, Masahiro, Yano, Seiji, Giaccone, Giuseppe, Tamura, Tomohide, Nakagawa, Kazuhiko, Douillard, Jean-Yves, Nishiwaki, Yutaka, Vansteenkiste, Johan, Kudoh, Shinzoh, Rischin, Danny, Eek, Richard, Horai, Takeshi, Noda, Kazumasa, Takata, Ichiro, Smit, Egbert, Averbuch, Steven, Macleod, Angela, Feyereislova, Andrea, Dong, Rui-Ping, Baselga, José
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Abstract CT212: Expanded phase 1/2a study of PLX8394, a novel next generation BRAF inhibitor in patients with advanced, unresectable solid tumors with alterations in BRAF
Janku, Filip, Sherman, Eric, Yaeger, Rona, Parikh, Aparna, Sullivan, Ryan, Feun, Lynn, Fuente, Macarena De La, Tsai, Frank Yung-Chin, Gordon, Michael, Allen, Carl, Rudoltz, Marc S., Balinski, Kathe, Averbuch, Steven, Vidne, Michael, Tarcic, Gabi
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract CT143: Pooled analysis of PD-L1 expression across 6 tumor types in the nivolumab clinical program
Krigsfeld, Gabriel, Novotny, James, Oroudjev, Emin, Carnahan, Josette, Zuo, Songlan, Averbuch, Steven D., Burns, Virginia
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article